Arabic SAMANTA Questionnaire for Heavy Menstrual Bleeding Diagnosis
This study aims to observe how accurately the Arabic version of the SAMANTA Questionnaire diagnoses heavy menstrual bleeding in individuals experiencing this condition.
Data Collection
Collected at a single point in time - Cross-sectionalUrogenital Diseases+9
+ Genital Diseases
+ Female Urogenital Diseases and Pregnancy Complications
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Summary
Study start date: December 1, 2025
Actual date on which the first participant was enrolled.This study focuses on improving the diagnosis of heavy menstrual bleeding (HMB) among non-pregnant women of reproductive age in Arabic-speaking regions. HMB can significantly affect a woman's quality of life by causing excessive menstrual blood loss that interferes with physical, social, and emotional well-being. Despite its high prevalence, there are few culturally adapted tools to diagnose HMB accurately in these regions. This study aims to adapt and validate the Arabic version of the SAMANTA questionnaire, a tool that could help identify women experiencing HMB and assess its impact on their lives, thereby addressing an unmet need for effective screening methods in low-resource settings. Participants in this study will complete the Arabic version of the SAMANTA questionnaire, which seeks to identify individuals experiencing heavy menstrual bleeding and assess how it affects their daily lives. The study evaluates the accuracy of this questionnaire as a diagnostic tool by testing its reliability and validity. Unlike complex methods that measure menstrual blood loss in research settings, this questionnaire offers a simple, cost-effective way to screen for HMB and its effects. The results aim to provide a practical solution for early and accurate diagnosis, potentially improving the quality of life for women affected by this condition.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.120 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 15 to 45 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives